Clinical Evaluation of Bioactive Resin Sealants vs Conventional Sealants in Permanent Molars
1 other identifier
interventional
38
0 countries
N/A
Brief Summary
This study will be conducted to evaluate the performance; in terms of retention and caries inhibition; of the newly introduced bioactive resin based pits and fissure sealant versus conventional resin based pits and fissure sealant in caries susceptible fissures in posterior molars in patients at risk of caries. Evaluation will be done by visual tactile examination \& VistaCAM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jan 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedJanuary 15, 2019
January 1, 2019
1 year
December 17, 2018
January 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Retention of sealant
rate of sealant loss
one year
Secondary Outcomes (1)
Caries incidence
one year
Study Arms (2)
conventional group
ACTIVE COMPARATORConventional resin based Pits \& fissures sealant 3M™ Clinpro™ Sealant is administrated
bioactive group
EXPERIMENTALBioactive Pits \& fissures sealant BioCoat® by Premier®.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with bilateral caries susceptible fissures in molars showing no signs of caries.
- years.
- Males or Females.
- Co-operative patients approving to participate in the trial.
You may not qualify if:
- Patients younger than 19 years old or older than 40 years old.
- Pregnancy.
- Disabilities.
- Systemic disease or severe medical complications.
- Allergic history concerning methacrylate.
- Rampant caries.
- Heavy smoking.
- Xerostomia.
- Lack of compliance.
- Evidence of severe bruxism, clenching, or tempromandibular joint disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
December 17, 2018
First Posted
December 19, 2018
Study Start
January 1, 2019
Primary Completion
January 1, 2020
Study Completion
March 1, 2020
Last Updated
January 15, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share